These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 9260328)

  • 1. Lessons from genetic models of inflammatory bowel disease.
    Podolsky DK
    Acta Gastroenterol Belg; 1997; 60(2):163-5. PubMed ID: 9260328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation.
    Powrie F; Leach MW
    Ther Immunol; 1995 Apr; 2(2):115-23. PubMed ID: 8729882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin.
    Bertrand V; Quéré S; Guimbaud R; Sogni P; Chauvelot-Moachon L; Tulliez M; Lamarque D; Charreire J; Giroud JP; Couturier D; Chaussade S; Breban M
    Eur Cytokine Netw; 1998 Jun; 9(2):161-70. PubMed ID: 9681392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New prebiotics from rice bran ameliorate inflammation in murine colitis models through the modulation of intestinal homeostasis and the mucosal immune system.
    Komiyama Y; Andoh A; Fujiwara D; Ohmae H; Araki Y; Fujiyama Y; Mitsuyama K; Kanauchi O
    Scand J Gastroenterol; 2011 Jan; 46(1):40-52. PubMed ID: 20735154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease.
    Mizoguchi A; Mizoguchi E; Chiba C; Spiekermann GM; Tonegawa S; Nagler-Anderson C; Bhan AK
    J Exp Med; 1996 Mar; 183(3):847-56. PubMed ID: 8642289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation.
    Westendorf AM; Templin M; Geffers R; Deppenmeier S; Gruber AD; Probst-Kepper M; Hansen W; Liblau RS; Gunzer F; Bruder D; Buer J
    Gut; 2005 Jan; 54(1):60-9. PubMed ID: 15591505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A defect in epithelial barrier integrity is not required for a systemic response to bacterial antigens or intestinal injury in T cell receptor-alpha gene-deficient mice.
    Sydora BC; Tavernini MM; Doyle J; Fedorak RN
    Inflamm Bowel Dis; 2006 Aug; 12(8):750-7. PubMed ID: 16917231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microbiota and inflammatory bowel disease: insights from animal models.
    Peloquin JM; Nguyen DD
    Anaerobe; 2013 Dec; 24():102-6. PubMed ID: 23603043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Many inflammatory bowel disease risk loci include regions that regulate gene expression in immune cells and the intestinal epithelium.
    Mokry M; Middendorp S; Wiegerinck CL; Witte M; Teunissen H; Meddens CA; Cuppen E; Clevers H; Nieuwenhuis EE
    Gastroenterology; 2014 Apr; 146(4):1040-7. PubMed ID: 24333384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice.
    Mombaerts P; Mizoguchi E; Grusby MJ; Glimcher LH; Bhan AK; Tonegawa S
    Cell; 1993 Oct; 75(2):274-82. PubMed ID: 8104709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the mucosal immune system in inflammatory bowel disease.
    MacDermott RP
    J Gastroenterol; 1996 Dec; 31(6):907-16. PubMed ID: 9027661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease.
    Hahm KB; Im YH; Parks TW; Park SH; Markowitz S; Jung HY; Green J; Kim SJ
    Gut; 2001 Aug; 49(2):190-8. PubMed ID: 11454793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of pro-inflammatory cytokines by TCR alpha beta+ and TCR gamma delta+ T cells in an experimental model of colitis.
    Simpson SJ; Holländer GA; Mizoguchi E; Allen D; Bhan AK; Wang B; Terhorst C
    Eur J Immunol; 1997 Jan; 27(1):17-25. PubMed ID: 9021993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of IL-10 in inflammatory bowel disease: "of mice and men".
    Leach MW; Davidson NJ; Fort MM; Powrie F; Rennick DM
    Toxicol Pathol; 1999; 27(1):123-33. PubMed ID: 10367687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathophysiology of inflammatory bowel disease: how genetics link barrier dysfunction and innate immunity to inflammation.
    Mehta M; Ahmed S; Dryden G
    Innate Immun; 2017 Aug; 23(6):497-505. PubMed ID: 28770665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unravelling the pathogenesis of inflammatory bowel disease.
    Xavier RJ; Podolsky DK
    Nature; 2007 Jul; 448(7152):427-34. PubMed ID: 17653185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal T cells as a target for treatment of IBD.
    Watanabe M; Yamazaki M; Kanai T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():48-50. PubMed ID: 12698871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of cytokine mRNA expression in intestinal biopsies of cats with inflammatory enteropathy using quantitative real-time RT-PCR.
    Nguyen Van N; Taglinger K; Helps CR; Tasker S; Gruffydd-Jones TJ; Day MJ
    Vet Immunol Immunopathol; 2006 Oct; 113(3-4):404-14. PubMed ID: 16879876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.